HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$13.45
Day range
$13.50 - $14.79
Year range
$3.39 - $20.72
Market cap
317.90M USD
Avg Volume
662.52K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 59.00K | -69.27% |
Operating expense | 46.36M | 482.08% |
Net income | -13.72M | 61.18% |
Net profit margin | -23.25K | -26.34% |
Earnings per share | -0.37 | 86.50% |
EBITDA | -19.73M | -48.95% |
Effective tax rate | -0.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 98.34M | -26.91% |
Total assets | 116.46M | -22.74% |
Total liabilities | 33.41M | 88.75% |
Total equity | 83.05M | — |
Shares outstanding | 22.79M | — |
Price to book | 3.00 | — |
Return on assets | -40.86% | — |
Return on capital | -56.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -13.72M | 61.18% |
Cash from operations | -14.25M | 5.30% |
Cash from investing | 2.40M | — |
Cash from financing | 687.00K | -98.99% |
Net change in cash | -11.16M | -121.19% |
Free cash flow | -20.75M | 68.62% |
About
Founded
2011
Headquarters
Website
Employees
33
